Global Life Sciences Industry Outlook, 2018

Global Life Sciences Industry to Reach $1.5 T by 2022, Driven by Innovative Google, Amazon, Facebook, Apple (GAFA) Partnerships and R&D IT Investments

USD 4,950.00

* Required Fields

USD 4,950.00

PAY BY INVOICE

Be the first to review this product

The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from payers to providers have provided a strong impetus to the growth of the life sciences industry. The convergence of biopharmaceuticals, drug delivery devices, and companion diagnostics enabled by the digital connectivity is driving regulatory and commercial changes in many exciting ways for the industry. With the synergistic effect of advanced technologies, such as Art

Key Issues Addressed

  • What are the main factors that will influence the size and direction of the global life sciences industry in 2018?
  • How does the industry outlook vary from region to region?
  • What is the outlook for pharmaceutical & biotechnology and IVD & research tools in each region during 2018?
  • What technology developments in the global life sciences industry in 2017 will have an impact during 2018?
  • What will be the key growth opportunities and strategic imperatives for companies in 2018?

Table of Contents

1. Executive Summary
Key Findings
Top Predictions for 2018—Global Life Sciences Industry
Top Trends for 2018—Global Life Sciences Industry
The 2017 Global Life Sciences Industry—Actuals Versus Forecast
Global Life Sciences Industry Sales Forecast—2018
Global Life Sciences Industry Sales by Region in 2017 and 2018
2018 Global Perspective—Developed Markets
2018 Global Perspective—Emerging Markets
2. Research Scope, Objectives, Methodology, and Background
Research Scope and Segmentation
Market Segmentation—Pharma & Biotech
Market Segmentation—IVD & Research Tools
Research Aims and Objectives
3. 2018 Pharmaceutical & Biotechnology Outlook
Global Pharma & Biotech Market Revenue Forecast
Global Pharmaceutical Sales in 2016 and 2017—A Snapshot
Key 2018 Pharmaceutical & Biotechnology Market Trends
Prediction 1—Drug Discovery and Clinical Development IT Solutions Spend to Exceed $10 B in 2018
Prediction 2—Outsourcing of Bio-analytical and cGMP Services will Breach the
Prediction 3—Small and Mid-sized Companies Attracting Big Pharma
2018 Regional Outlook—Pharma & Biotech Market
Key Regional Market—US
Key Regional Market—Europe
Key European Markets
Key Regional Market—Japan
Key Regional Market—China
Key Regional Market—India
Key APAC Markets
Key Regional Pharma Market—Latin America
Key Regional Pharma Market—Brazil
Key Regional Market—Africa
Disruptive Market Participants
4. 2018 IVD & Research Tools Outlook
Global IVD Market Revenue Forecast
Global Research Tools Market Forecast
Global IVD Sales in 2016 and 2017—A Snapshot
Key 2018 IVD & Research Tools Market Trends
Prediction 1—Investment Capital will Continue to Pour for Liquid Biopsy Technologies
Prediction 2—Disruptive Start-ups Take Lead in Oncology and Big Data
Prediction 3—Reimbursement and Regulatory Headwinds Impact IVD Companies in Major Geographies
Prediction 4—Research labs jump-start spending on Cloud, NGS & Big Data analytics solutions
2018 Regional Outlook—IVD Market
Key Regional Market—US
Key Regional Market—Europe
Key European Markets
Key Regional Market—Japan
Key Regional Market—China
Key Regional Market—India
Key APAC Markets
Key Regional Market—Latin America
Key Regional Market—Brazil
Key Regional Market—Africa
Disruptive Start-Ups Aiming for Next-generation Diagnostics
5. Global Life Sciences Industry Technology Outlook
New Product/Technology/Service Approval/Launches 2017
Key Converging Technologies for Pharma & Biotech Industry Driving Data Integrity and Continuity Across the Value Chain
Key Converging Technologies for Diagnostics & Research Tools Industry Driving Healthcare Consumerization
6. Growth Opportunities and Companies to Action
5 Major Growth Opportunities
Growth Opportunity 1—Immuno-oncology
Growth Opportunity 2—Cell Banking
Growth Opportunity 3—Single-use Manufacturing
Growth Opportunity 4—Point of Care Testing
Growth Opportunity 5—Genomics
Strategic Imperatives for Life Sciences Companies
7. Key Conclusions and Future Outlook
Key Conclusions and Future Outlook
Legal Disclaimer
8. Appendix
List of Exhibits
Abbreviations and Terms Used
Pharma 2.0 2018 Titles
Next Generation Diagnostics & Research Tools 2018 Titles
Additional Sources of Information
9. The Frost & Sullivan Story


List of Figures & Charts

1. Life Sciences Industry: Revenue Forecast by Region, 2018
2. Life Sciences Outlook: Sales by Region, 2017 and 2018
3. Pharma & Biotech Market: Revenue Forecast, Global, 2016–2022
4. Pharma & Biotech Market: Revenue Breakout by Segment, Global, 2018*
5. Pharmaceutical Sales, Global, 2016 and 2017E
6. Pharma Market: Revenue Breakout by Regions, Global, 2018*
7. Global Life Sciences Outlook: Disruptive Market Participants, 2018
8. IVD Market: Revenue Forecast, Global, 2016–2022
9. IVD Market: Revenue Breakout by Segment, Global, 2018*
10. Research Tools Market: Revenue Forecasts, Global, 2016–2022
11. Life Science Research Tools: Revenue Breakdown, Global, 2018*
12. IVD Sales, Global, 2016 and 2017E
13. IVD Market: Revenue Breakout by Regions, Global, 2018*
14. Life Sciences Predictions, Disruptive Start-ups, Global, 2018



Keyword1
life sciences
Keyword2

Keyword3
life sciences

Related Research

Release Date : 29-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.